Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Peripheral stem cell transplantation may be able to replace immune cells that were
destroyed by chemotherapy or radiation therapy used to kill tumor cells.
PURPOSE: Phase II trial to study the effectiveness of peripheral stem cell transplantation
from related donors to prevent graft-versus-host disease in treating patients with
hematologic cancer.
Phase:
Phase 2
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore